To model this disease, CTX iPSCs were generated from dermal fibroblasts of a CTX patient with mutations in the CYP27A1 gene using an integration-free episomal method by transducing cells with episomal vectors containing Oct3/4, Sox2, Klf4, and L-Myc [22]. This evidence concerns the gene SOX2 and cerebrotendinous xanthomatosis.